What a Dermaplaning Machine Is and How It Works
A dermaplaning machine is a handheld device that uses a sterile surgical scalpel to gently scrape the skin's surface, removing dead cells and fine vellus hair. The procedure, often called dermaplaning or microplaning, is performed by dermatologists, licensed aestheticians, and in some cases at home with FDA-cleared devices. The market includes both professional-grade systems for clinics and consumer devices for personal use, with the global aesthetic devices market valued at over $20 billion and growing steadily as demand for noninvasive treatments increases according to industry analysis.
Professional dermaplaning machines typically feature a blade holder and a single-use blade, with systems from companies like Dermaplaning Tool and Feather Touch offering ergonomic designs for controlled exfoliation. Consumer devices, such as those from PMD Beauty and NuFACE, use oscillating or vibrating blades to mimic the clinical technique at lower intensity. These devices are classified as cosmetic tools and are not intended to diagnose, treat, or cure any skin condition, which distinguishes them from regulated medical devices.
Costs, Revenue Models, and Market Positioning
In-clinic dermaplaning treatments cost between $50 and $150 per session in the United States, with full-face procedures averaging around $75 according to data from the American Society for Dermatologic Surgery. Professional machines for clinics range from $300 to $2,000 depending on brand, blade capacity, and included accessories, while consumer-grade devices retail for $20 to $200. Revenue for medspas and dermatology practices often bundles dermaplaning with chemical peels or facials, with add-on procedures generating an average incremental revenue of $40 to $75 per visit.
The competitive landscape includes established medical device manufacturers and newer direct-to-consumer brands. Companies such as AccuTec and Feather Touch supply professional blades and handles to clinics, while brands like PMD Beauty and Schick target the home-use segment through retail and e-commerce channels. The market is segmented by end user, with professional devices holding a larger share due to higher per-unit price and repeat consumable blade sales driving recurring revenue.
Regulatory Framework and Investment Considerations
Dermaplaning machines for professional use are typically Class I or Class II medical devices regulated by the U.S. Food and Drug Administration, with many cleared through the 510(k) pathway as exfoliation instruments. Consumer devices are generally marketed as cosmetic tools and do not require FDA clearance, though they must comply with general safety and labeling regulations. Investors and business owners should verify clearance status and adhere to state-level licensing requirements for practitioners performing the procedure.
Financial analysts tracking the aesthetic devices sector note that noninvasive procedures, including dermaplaning, have grown faster than surgical aesthetics in recent years, supported by increasing consumer preference for minimal downtime treatments. Publicly traded companies in the medical aesthetics space, such as Almirall and Lumen & Company, provide quarterly data that can serve as proxies for market trends, while private equity activity in medspa chains signals continued expansion